HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM

Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM trials appear

Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could one HPV vaccine dose protect for decades?

Knowledge-focused Ongoing

This study follows women for up to 20 years after they received HPV vaccines to see how long protection lasts. Researchers are comparing women who got one, two, or three doses to understand if fewer doses provide enough long-term immunity. By testing blood samples over time, they…

Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM

Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused

Last updated Mar 23, 2026 15:18 UTC

HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM

Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM trials appear

Could one HPV vaccine dose protect for decades?